News
Chemo Changes Fail to Improve Surgical Outcomes in Rectal Cancer
- Author:
- Richard Hyer
Major Finding: Surgical down-staging rates were similar in comparisons of CVI 5-FU vs. capecitabine (20.7% and 23%, respectively) and oxaliplatin...
News
Hepcidin Levels Predict ESA and IV Iron Responses
- Author:
- Richard Hyer
Major Finding: Forty-seven patients with lower serum hepcidin levels who received darbepoetin and four to five doses of intravenous iron had...
News
U.K. Study Links Dietary Fat to Esophageal Cancer Risk
- Author:
- Richard Hyer
Major Finding: Total dietary fat and saturated fatty acids were found to be positively associated with esophageal adenocarcinoma, but not with...
News
U.K. Study Links Dietary Fat to Esophageal Cancer Risk
- Author:
- Richard Hyer
Major Finding: Total dietary fat and saturated fatty acids were found to be positively associated with esophageal adenocarcinoma, but not with...
News
U.K. Study Links Dietary Fat to Esophageal Cancer Risk
- Author:
- Richard Hyer
Major Finding: Total dietary fat and saturated fatty acids were found to be positively associated with esophageal adenocarcinoma, but not with...
News
Imaging Combo May Diagnose Gastric Cancer Without Biopsy
- Author:
- Richard Hyer
Major Finding: Magnifying NBI improves the diagnostic performance of white light endoscopy for discriminating gastric cancer from benign small...
News
Imaging Combo May Diagnose Gastric Cancer Without Biopsy
- Author:
- Richard Hyer
Major Finding: Magnifying NBI improves the diagnostic performance of white light endoscopy for discriminating gastric cancer from benign small...
News
Imaging Combo May Diagnose Gastric Cancer Without Biopsy
- Author:
- Richard Hyer
Major Finding: Magnifying NBI improves the diagnostic performance of white light endoscopy for discriminating gastric cancer from benign small...
News
Novel Anticoagulant Prevents VTEs During Chemotherapy
- Author:
- Richard Hyer
Major Finding: The rate of VTE events was 1.2% in patients given prophylactic semuloparin vs. 3.4% in a control group treated with placebo (HR, 0....
News
Novel Anticoagulant Prevents VTEs During Chemotherapy
- Author:
- Richard Hyer
Major Finding: The rate of VTE events was 1.2% in patients given prophylactic semuloparin vs. 3.4% in a control group treated with placebo (HR, 0....
News
Novel Anticoagulant Prevents VTEs During Chemotherapy
- Author:
- Richard Hyer
Major Finding: The rate of VTE events was 1.2% in patients given prophylactic semuloparin vs. 3.4% in a control group treated with placebo (HR, 0....
News
Denosumab Not Cost Effective in Solid Tumor Bone Metastases
- Author:
- Richard Hyer
Major Finding: Use of denosumab results in an incremental cost per QALY gained of $644,000 in breast cancer and $1.25 million in prostate cancer....
News
Denosumab Not Cost Effective in Solid Tumor Bone Metastases
- Author:
- Richard Hyer
Major Finding: Use of denosumab results in an incremental cost per QALY gained of $644,000 in breast cancer and $1.25 million in prostate cancer....
News
Axitinib Extends Progression-Free Survival in Kidney Cancer Trial
- Author:
- Richard Hyer
Major Finding: Patients treated with axitinib had a median progression-free survival of 6.7 months vs.
News
Axitinib Extends Progression-Free Survival in Kidney Cancer Trial
- Author:
- Richard Hyer
Major Finding: Patients treated with axitinib had a median progression-free survival of 6.7 months vs.